- Home
- NVNO vs TURN Comparison
NVNO vs TURN Comparison
Compare NVNO & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- TURN
- Stock Information
- Founded
- NVNO 1987
- TURN 1981
- Country
- NVNO United States
- TURN United States
- Employees
- NVNO N/A
- TURN N/A
- Industry
- NVNO Medical/Dental Instruments
- TURN Finance/Investors Services
- Sector
- NVNO Health Care
- TURN Finance
- Exchange
- NVNO Nasdaq
- TURN Nasdaq
- Market Cap
- NVNO 41.0M
- TURN 39.9M
- IPO Year
- NVNO N/A
- TURN N/A
- Fundamental
- Price
- NVNO $3.51
- TURN $3.95
- Analyst Decision
- NVNO
- TURN
- Analyst Count
- NVNO 0
- TURN 0
- Target Price
- NVNO N/A
- TURN N/A
- AVG Volume (30 Days)
- NVNO 80.1K
- TURN 20.7K
- Earning Date
- NVNO 07-30-2025
- TURN 06-10-2025
- Dividend Yield
- NVNO N/A
- TURN N/A
- EPS Growth
- NVNO N/A
- TURN N/A
- EPS
- NVNO N/A
- TURN N/A
- Revenue
- NVNO N/A
- TURN $194,813.00
- Revenue This Year
- NVNO N/A
- TURN N/A
- Revenue Next Year
- NVNO $409.09
- TURN N/A
- P/E Ratio
- NVNO N/A
- TURN N/A
- Revenue Growth
- NVNO N/A
- TURN 254.25
- 52 Week Low
- NVNO $2.03
- TURN $3.12
- 52 Week High
- NVNO $6.48
- TURN $4.25
- Technical
- Relative Strength Index (RSI)
- NVNO 52.54
- TURN 47.58
- Support Level
- NVNO $3.26
- TURN $3.91
- Resistance Level
- NVNO $3.81
- TURN $4.18
- Average True Range (ATR)
- NVNO 0.26
- TURN 0.24
- MACD
- NVNO -0.04
- TURN -0.02
- Stochastic Oscillator
- NVNO 33.78
- TURN 30.23
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.